Worth Venture Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-440,988
Closed -$6.96M 71
2023
Q4
$6.96M Buy
440,988
+12,621
+3% +$130K 3.76% 5
2023
Q3
$3.68M Buy
+428,367
New +$3.04M 2.19% 8
2023
Q1
Sell
-250,250
Closed -$2.95M 190
2022
Q4
$2.95M Buy
+250,250
New +$2.86M 1.74% 19
2021
Q3
Sell
-146,687
Closed -$4.39M 131
2021
Q2
$4.39M Hold
146,687
1.63% 20
2021
Q1
$2.98M Sell
146,687
-22,354
-13% -$472K 1.45% 21
2020
Q4
$2.82M Sell
169,041
-6,445
-4% -$84.7K 2.23% 18
2020
Q3
$1.92M Buy
175,486
+50,999
+41% +$403K 1.58% 16
2020
Q2
$819K Sell
124,487
-83,657
-40% -$537K 0.4% 37
2020
Q1
$1.28M Buy
208,144
+34,635
+20% +$281K 0.79% 19
2019
Q4
$1.35M Hold
173,509
0.66% 22
2019
Q3
$1.03M Sell
173,509
-34,300
-17% -$218K 0.59% 25
2019
Q2
$1.48M Buy
+207,809
New +$943K 0.82% 20

Other funds holding ASPN

Worth Venture Partners's ASPN Position: Q1 2024 in Review

Worth Venture Partners sold out of Aspen Aerogels (ASPN) in Q1 2024, closing a stake of 440,988 shares — an estimated $6.96M sold.

Worth Venture Partners first reported a position in ASPN in Q2 2019 and held it in 12 quarters. The position peaked at $6.96M in Q4 2023. 167 funds tracked by Wall St. Rank hold ASPN as of Q1 2024.

  • Worth Venture Partners reported no remaining Aspen Aerogels position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 440,988 Aspen Aerogels shares in Q1 2024, an estimated $6.96M.
  • Worth Venture Partners first reported a position in Aspen Aerogels in Q2 2019 and held it in 12 quarters.
  • Worth Venture Partners's Aspen Aerogels position peaked at $6.96M in Q4 2023.
  • 167 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.